Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 14, 2020 - Issue
Submit an article Journal homepage
183
Views
9
CrossRef citations to date
0
Altmetric
Original Research

LncRNA PVT1 Suppresses the Progression of Renal Fibrosis via Inactivation of TGF-β Signaling Pathway

Lu Cao1 Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, People’s Republic of ChinaCorrespondence[email protected]
,
Peng Qin2 Department of Cancer Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan 450000, People’s Republic of China
,
Jianjiang Zhang1 Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, People’s Republic of China
,
Huiju Qiao1 Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, People’s Republic of China
,
Peipei Shi1 Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, People’s Republic of China
&
Huali Huo1 Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, People’s Republic of China
Pages 3547-3557 | Published online: 26 Aug 2020

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Vishwadeep Shelke, Ajinath Kale, Himanshu Sankrityayan, Hans-Joachim Anders & Anil Bhanudas Gaikwad. (2024) Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease. Archives of Physiology and Biochemistry 130:2, pages 230-241.
Read now
Huanhou Su, Jingzhou Xie, Lijing Wen, Shunyi Wang, Sishuo Chen, Jiangchao Li, Cuiling Qi, Qianqian Zhang, Xiaodong He, Lingyun Zheng & Lijing Wang. (2021) LncRNA Gas5 Regulates Fn1 Deposition Via Creb5 in Renal Fibrosis. Epigenomics 13:9, pages 699-713.
Read now

Articles from other publishers (7)

Jinping Hu, Xiaoyan Zhang, Feng Ma, Chen Huang & Yali Jiang. (2024) LncRNA CASC2 Alleviates Renal Interstitial Inflammation and Fibrosis through MEF2C Downregulation-Induced Hinderance of M1 Macrophage Polarization. Nephron 148:4, pages 245-263.
Crossref
Francesca Giannuzzi, Silvia Maiullari, Loreto Gesualdo & Fabio Sallustio. (2023) The Mission of Long Non-Coding RNAs in Human Adult Renal Stem/Progenitor Cells and Renal Diseases. Cells 12:8, pages 1115.
Crossref
Cristine Dieter, Natália Emerim Lemos, Eliandra Girardi, Denise Taurino Ramos, Felipe Mateus Pellenz, Luís Henrique Canani, Taís Silveira Assmann & Daisy Crispim. (2022) The rs3931283/PVT1 and rs7158663/MEG3 polymorphisms are associated with diabetic kidney disease and markers of renal function in patients with type 2 diabetes mellitus. Molecular Biology Reports 50:3, pages 2159-2169.
Crossref
Yan Chen, Chong Huang, Zhi-Bin Duan, Yan-Xia Chen & Cheng-Yun Xu. (2023) LncRNA NEAT1 accelerates renal fibrosis progression via targeting miR-31 and modulating RhoA/ROCK signal pathway. American Journal of Physiology-Cell Physiology 324:2, pages C292-C306.
Crossref
Helen Mok, Ahmed Al-Jumaily & Jun Lu. (2022) Plasmacytoma Variant Translocation 1 (PVT1) Gene as a Potential Novel Target for the Treatment of Diabetic Nephropathy. Biomedicines 10:11, pages 2711.
Crossref
Chenxin Liu, Kuai Ma, Yunchao Zhang, Xing He, Linjiang Song, Mingxuan Chi, Zhongyu Han, Guanhua Li, Qinxiu Zhang & Chi Liu. (2022) Kidney diseases and long non-coding RNAs in the limelight. Frontiers in Physiology 13.
Crossref
Taotao Hu, Fang Chen, Dan Chen & Hongqing Liang. (2022) DNMT3a negatively regulates PTEN to activate the PI3K/AKT pathway to aggravate renal fibrosis. Cellular Signalling 96, pages 110352.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.